quality assurance programme definition

quality assurance programme means a systematic programme of controls and inspections by any organisation or body involved in the transport of radioactive material that is aimed at providing adequate confidence that the standard of safety prescribed in these Regulations is achieved in practice and is more fully described in regulation 18;
quality assurance programme means a systematic programme of controls and inspections applied by any person which is aimed at providing confidence that the safety requirements of these Regulations and RID are complied with;
quality assurance programme means a programme described in paragraph 12 of this Order.

More Definitions of quality assurance programme

quality assurance programme means an industry approved certified quality
quality assurance programme means a defined system, including personnel, which is independent of study conduct and is designed to assure test facility management of compliance with the principles of good laboratory practice;

Related to quality assurance programme

  • Quality Assurance Program means the overall quality program and associated activities including the Department’s Quality Assurance, Design-Builder Quality Control, the Contract’s quality requirements for design and construction to assure compliance with Department Specifications and procedures.

  • Quality Assurance means the quality assurance documentation, including but not limited to the quality records, method statements, description of the production and work procedures etc. as required under Purchaser’s, Customer’s and/or Supplier’s quality requirements.

  • Quality Assurance Plan or “QAP” shall have the meaning set forth in Clause 11.2;

  • Quality Management Plan means the portion of the Project Development Plan providing the information requested in Section 4.3 of Exhibit B to the ITP.

  • Radiopharmaceutical quality assurance means, but is not limited to, the performance of appropriate chemical, biological, and physical tests on potential radiopharmaceuticals and the interpretation of the resulting data to determine their suitability for use in humans and animals, including internal test assessment, authentication of product history, and the keeping of proper records.